Alimentary Pharmacology & Therapeutics

(ISSN: 0269-2813, 1365-2036)

Subscribe Submit

Articles Available on Medscape

 
 

Alimentary Pharmacology & Therapeutics's Latest Table of Contents

2017 - 45 (8)

  • Systematic review with meta-analysis: the efficacy and safety of CT-P13, a biosimilar of anti-tumour necrosis factor-α agent (infliximab), in inflammatory bowel diseases. 
  • Epidemiology of inflammatory bowel disease among participants of the Millennium Cohort: incidence, deployment-related risk factors, and antecedent episodes of infectious gastroenteritis. 
  • Randomised clinical trial: the efficacy and safety of oltipraz, a liver X receptor alpha-inhibitory dithiolethione in patients with non-alcoholic fatty liver disease. 
  • Systematic review with meta-analysis: the impact of Clostridium difficile infection on the short- and long-term risks of colectomy in inflammatory bowel disease. 
  • Inflammatory bowel diseases in Faroese-born Danish residents and their offspring: further evidence of the dominant role of environmental factors in IBD development. 
 
 

Mission Statement: Alimentary Pharmacology & Therapeutics , a gastroenterology journal specializing in clinical aspects of gastroenterology.

Member of Medscape Publishers’ Circle®